- Home
- PXS vs RFL Comparison
PXS vs RFL Comparison
Compare PXS & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PXS
- RFL
- Stock Information
- Founded
- PXS 2015
- RFL 2017
- Country
- PXS Greece
- RFL United States
- Employees
- PXS N/A
- RFL N/A
- Industry
- PXS Marine Transportation
- RFL Real Estate
- Sector
- PXS Consumer Discretionary
- RFL Finance
- Exchange
- PXS Nasdaq
- RFL Nasdaq
- Market Cap
- PXS 53.9M
- RFL 48.4M
- IPO Year
- PXS N/A
- RFL N/A
- Fundamental
- Price
- PXS $5.00
- RFL $2.40
- Analyst Decision
- PXS Strong Buy
- RFL
- Analyst Count
- PXS 1
- RFL 0
- Target Price
- PXS $10.00
- RFL N/A
- AVG Volume (30 Days)
- PXS 18.4K
- RFL 65.0K
- Earning Date
- PXS 11-18-2024
- RFL 12-12-2024
- Dividend Yield
- PXS N/A
- RFL N/A
- EPS Growth
- PXS 54.22
- RFL N/A
- EPS
- PXS 2.75
- RFL N/A
- Revenue
- PXS $50,062,000.00
- RFL $540,000.00
- Revenue This Year
- PXS $11.09
- RFL N/A
- Revenue Next Year
- PXS $5.68
- RFL N/A
- P/E Ratio
- PXS $1.82
- RFL N/A
- Revenue Growth
- PXS N/A
- RFL 92.86
- 52 Week Low
- PXS $3.55
- RFL $1.29
- 52 Week High
- PXS $5.53
- RFL $2.44
- Technical
- Relative Strength Index (RSI)
- PXS 47.72
- RFL 87.25
- Support Level
- PXS $4.92
- RFL $2.00
- Resistance Level
- PXS $5.04
- RFL $1.94
- Average True Range (ATR)
- PXS 0.10
- RFL 0.10
- MACD
- PXS -0.00
- RFL 0.03
- Stochastic Oscillator
- PXS 40.63
- RFL 94.85
About PXS Pyxis Tankers Inc.
Pyxis Tankers Inc is an international maritime transportation company that focuses on the product tanker sector. It owns a fleet that comprises double-hull product tankers employed under a mix of short- and medium-term time charters and spot charters. The fleet owned by the company includes Pyxis Epsilon, Pyxis Theta, Pyxis Malou, Northsea Alpha, and Northsea Beta. Each of the vessels in the fleet is capable of transporting refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel, fuel oil, and other liquid bulk items, such as vegetable oils and organic chemicals.
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.